Geoffrey Kelly

949 total citations
7 papers, 195 citations indexed

About

Geoffrey Kelly is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Geoffrey Kelly has authored 7 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Geoffrey Kelly's work include Viral Infections and Outbreaks Research (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Protein Degradation and Inhibitors (2 papers). Geoffrey Kelly is often cited by papers focused on Viral Infections and Outbreaks Research (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Protein Degradation and Inhibitors (2 papers). Geoffrey Kelly collaborates with scholars based in United States, United Kingdom and Germany. Geoffrey Kelly's co-authors include Nancy J. Thompson, Dixie E. Snider, George M. Cauthen, J O Kilburn, W.D. Jones, Robert C. Good, Christine Grady, Bhaskar Upadhyaya, Seunghee Kim‐Schulze and Manishkumar Patel and has published in prestigious journals such as Blood, Experimental Biology and Medicine and Cytometry Part A.

In The Last Decade

Geoffrey Kelly

7 papers receiving 169 citations

Peers

Geoffrey Kelly

ID

EPIDE

SURGE

MB

IMMUN

Sidra Ezídio Gonçalves Vasconcellos Brazil

Mariane Martins Araújo Stefani Brazil

Mohammad Rezaei Zadeh Rukerd Iran

Jennifer L. Saullo United States

Yoko Kita Japan

Akiko Okawara Japan

Samuel Bremang United Kingdom

Anne Dao France

Mickey Kertesz United States

A. Eiras Spain

Sidra Ezídio Gonçalves Vasconcellos Brazil

Geoffrey Kelly

216 ×1.4

ID

198 ×1.5

EPIDE

120 ×1.8

SURGE

36 ×1.2

MB

26 ×1.3

IMMUN

Citations per year, relative to Geoffrey Kelly Geoffrey Kelly (= 1×) peers Sidra Ezídio Gonçalves Vasconcellos

Countries citing papers authored by Geoffrey Kelly

Since Specialization

Citations

This map shows the geographic impact of Geoffrey Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Kelly more than expected).

Fields of papers citing papers by Geoffrey Kelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Kelly. The network helps show where Geoffrey Kelly may publish in the future.

Co-authorship network of co-authors of Geoffrey Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Kelly. A scholar is included among the top collaborators of Geoffrey Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Kelly. Geoffrey Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Chen, Lucia, Oliver Van Oekelen, Michael Amatangelo, et al.. (2023). Mezigdomide Treatment in Relapsed-Refractory Myeloma Patients Shifts Bone Marrow NK and T Cell Populations from Exhaustion to Activation. Blood. 142(Supplement 1). 4686–4686. 4 indexed citations

2.

Fenutría, Rafael, Dabeiba Bernal‐Rubio, Annika Hunziker, et al.. (2022). The dengue virus 4 component of NIAID’s tetravalent TV003 vaccine drives its innate immune signature. Experimental Biology and Medicine. 247(24). 2201–2212. 3 indexed citations

3.

Oekelen, Oliver Van, Michael Amatangelo, Manman Guo, et al.. (2021). Large-Scale Mass Cytometry Reveals Significant Activation of Innate and Adaptive Immunity in Bone Marrow Tumor Microenvironment of Iberdomide-Treated Myeloma Patients. Blood. 138(Supplement 1). 730–730. 7 indexed citations

4.

Geanon, Daniel, Brian Lee, Edgar Gonzalez‐Kozlova, et al.. (2021). A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID ‐19. Cytometry Part A. 99(5). 446–461. 23 indexed citations

5.

Grady, Christine & Geoffrey Kelly. (1996). State of the science. HIV vaccine development.. PubMed. 31(1). 25–39. 5 indexed citations

6.

Snider, Dixie E., Geoffrey Kelly, George M. Cauthen, Nancy J. Thompson, & J O Kilburn. (1985). Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli.. PubMed. 132(1). 125–32. 122 indexed citations

7.

Jones, W.D., Robert C. Good, Nancy J. Thompson, & Geoffrey Kelly. (1982). Bacteriophage types of Mycobacterium tuberculosis in the United States.. PubMed. 125(6). 640–3. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact